RPO LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 13 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RPO LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q1 2023$33,903
+52.3%
56,505
-0.4%
0.01%
+25.0%
Q4 2022$22,262
-77.3%
56,705
-32.3%
0.01%
-66.7%
Q3 2022$98,000
+32.4%
83,7050.0%0.02%
+26.3%
Q2 2022$74,000
-53.5%
83,705
+2.4%
0.02%
-63.5%
Q1 2022$159,00081,7050.05%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 194,718$171,0000.22%
RPO LLC 83,705$74,0000.02%
Sio Capital Management, LLC 49,998$45,0000.02%
CVI Holdings, LLC 244,825$218,0000.02%
Exos Asset Management LLC 27,151$24,0000.01%
TUDOR INVESTMENT CORP ET AL 236,549$208,0000.01%
LMR Partners LLP 50,000$161,0000.00%
P SCHOENFELD ASSET MANAGEMENT LP 19,155$17,0000.00%
Verition Fund Management LLC 15,000$48,0000.00%
JANE STREET GROUP, LLC 56,444$50,0000.00%
View complete list of HUMACYTE INC shareholders